Wyeth have published a series of dual 5-HT1A /5-HT transporter inhibitors… more →
GPCR Newscrimsoncanary wrote 1 year ago: Wyeth have published a series of dual 5-HT1A /5-HT transporter inhibitors … more →
crimsoncanary wrote 1 year ago: Redordati have published a series of 1,4-dioxane 5-HT1A Full Agonists that are structurally related … more →
crimsoncanary wrote 1 year ago: OSI Pharmaceuticals have initiated a Phase I trial of its dual serotonin and norepinephrine reuptake … more →
crimsoncanary wrote 1 year ago: OSI have presented preclinical data on its dual 5-HT1A agonist/Monoamine reuptake inhibitor PSN602 w … more →
crimsoncanary wrote 1 year ago: Phase IIa data released by PsychoGenics show its lead partial 5-HT1A – 5-HT1B receptor agonist eltop … more →
crimsoncanary wrote 1 year ago: The FDA has approved Seroquel (quetiapine fumarate) for the maintenance treatment of patients with b … more →
crimsoncanary wrote 1 year ago: AstraZeneca have submitted a supplemental NDA for Seroquel XR for the Treatment of Generalised Anxie … more →